Regulations Constrain Stem Cell Research Across the Globe

See allHide authors and affiliations

Science  09 Aug 2002:
Vol. 297, Issue 5583, pp. 924
DOI: 10.1126/science.297.5583.924

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


U.S. researchers aren't the only ones facing delays acquiring human embryonic stem cells (see main text). Many of their colleagues in Europe and Asia are constrained by similar government regulations, and some still face outright bans on the work, which is controversial because it entails the destruction of an embryo but promises new types of treatments for a host of diseases. Science provides a snapshot of various regulations, many of which are still in flux.